Merck to add 150 employees at Durham plant
Posted April 25, 2011
DURHAM, N.C. — A major pharmaceutical company will add 150 workers in Durham as it expands to produce chickenpox and other live-virus vaccines.
The Herald-Sun of Durham reported Monday that Merck & Co.'s plant will begin producing finished Varivax, a chickenpox vaccine recently approved by the U.S. Food and Drug Administration.
Plant manager John Wagner said the number of workers at the site should reach 600 by the end of 2011.
Merck is expanding the plant, formally known as the Maurice R. Hilleman Center for Vaccine Manufacturing, from 200,000 square feet to 270,000 square feet.
The company also has plans to add vaccines for measles, mumps and rubella to its products, as well as a shingles vaccine for adults.
Information from: The Herald-Sun